Medical consensus once supported daily use of low dose aspirin to prevent heart attack and stroke in people at increased risk for cardiovascular disease (CVD). 

Genomic surveillance has revealed that malaria resistance to two first-line antimalarial drugs has spread rapidly from Cambodia to neighbouring countries in Southeast Asia. 

Treatments for Parkinson’s disease have most recently focused on increasing dopamine, a chemical messenger in the brain that affects reward-based behaviors and motivation, as well as movement.

A team of UC Davis Health scientists and physicians has identified a cellular connection between diabetes and one of its major complications — blood vessel narrowing that increases risks of several serious health conditions, including heart disease and stroke.

Researchers at the Weizmann Institute of Science have shown in mice that intestinal microbes, collectively termed the gut microbiome, may affect the course of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease.

A new study shows Americans are drilling deeper than ever for fresh water.

The enzyme ribonucleotide reductase is a bottleneck for cancer cell growth. 

In a study using yeast cells and data from cancer cell lines, Johns Hopkins University scientists report they have found a potential weak spot among cancer cells that have extra sets of chromosomes, the structures that carry genetic material. 

Healthcare in low- and middle-income countries is poorly prepared for the increasing number of high blood pressure (ie hypertension) disorders. 

Ever stand up too quickly and see stars? Fainting from low blood pressure can be dangerous for astronauts as well as for patients.